【维升药业-B(02561.HK)携手安科生物 加速长效生长激素中国商业化进程】智通财经APP获悉,维升药业-B(025

智通财经
15 Jul
【维升药业-B(02561.HK)携手安科生物 加速长效生长激素中国商业化进程】智通财经APP获悉,维升药业-B(02561.HK)7月14日宣布与安科生物(300009.SZ)签订战略合作框架协议。在合作期限内,维升药业授权安科生物在中国境内特定区域内排他性独家推广隆培促生长素产品。双方将共同推动维升核心产品隆培促生长素在中国市场的普及。此外,双方同意在其他目标产品上进行更广泛和深入的合作探讨,包括但不限于本地化生产、商业化推广合作等。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10